Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group
References (0)
Cited by (510)
The key role of gut–liver axis in pyrrolizidine alkaloid-induced hepatotoxicity and enterotoxicity
2021, Acta Pharmaceutica Sinica BCitation Excerpt :This result suggests that PA-induced intestinal injury may contribute to the development of IBD, of which the etiology is not fully understood. Notably, apart from the DSS model, other animal models of IBD exist, such as the interleukin-10 knockout mouse, which may present additional pathological features as well as etiological factors of human IBD37. Future studies incorporating PA exposure in these animal models are warranted to fully explore the role of PA exposure in IBD pathogenesis.
Targeted interleukin-10 plasmid DNA therapy in the treatment of osteoarthritis: Toxicology and pain efficacy assessments
2020, Brain, Behavior, and ImmunityPotential role of regulatory B cells in immunological diseases
2019, Immunology LettersHeterogeneity in Definitions of Efficacy and Safety Endpoints for Clinical Trials of Crohn's Disease: A Systematic Review
2018, Clinical Gastroenterology and HepatologyProgress in the pathogenesis and treatment of very early-onset inflammatory bowel disease caused by deficiency of interleukin-10 signaling pathway
2024, Chinese Journal of Applied Clinical Pediatrics
Copyright © 1997 Published by Elsevier Inc.